Chang David D

CIK 00016110242 companiesSANTA MONICA, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001611024

Recent Transactions

50 trades

Sale
Allogene Therapeutics, Inc.$ALLO
Common Stock
2025-03-14$1.96/sh−46,668→ 5,276,569 total
Sale
Allogene Therapeutics, Inc.$ALLO
Common Stock
2025-02-03$1.68/sh−46,003→ 5,317,237 total
Award
Allogene Therapeutics, Inc.$ALLO
Common Stock
2025-01-24+552,174→ 5,363,240 total
Award
Allogene Therapeutics, Inc.$ALLO
Stock Option (Right to buy)
2025-01-24+1,952,130→ 1,952,130 total
Award
Allogene Therapeutics, Inc.$ALLO
Common Stock
2024-05-16$2.90/sh+344,828→ 4,810,106 total
Tax Payment
Allogene Therapeutics, Inc.$ALLO
Common Stock
2024-03-14$4.33/sh−53,393→ 4,465,278 total
Award
Allogene Therapeutics, Inc.$ALLO
Common Stock
2024-01-25+317,800→ 4,513,203 total
Award
Allogene Therapeutics, Inc.$ALLO
Stock Option (Right to buy)
2024-01-25+1,123,535→ 1,123,535 total
Award
Allogene Therapeutics, Inc.$ALLO
Common Stock
2023-03-22+1,924,464→ 4,193,911 total
Award
Allogene Therapeutics, Inc.$ALLO
Stock Option (Right to Buy)
2023-03-22+1,492,200→ 1,492,200 total
Tax Payment
Allogene Therapeutics, Inc.$ALLO
Common Stock
2023-03-14$5.56/sh−22,340→ 2,269,447 total
Award
Allogene Therapeutics, Inc.$ALLO
Stock Option (Right to Buy)
2022-03-23+2,195,512→ 2,195,512 total
Sale
Allogene Therapeutics, Inc.$ALLO
Common Stock
2022-03-15$7.65/sh−23,648→ 2,289,652 total
Exercise/Conversion
Allogene Therapeutics, Inc.$ALLO
Common Stock
2021-05-24$18.22/sh+27,410→ 2,312,279 total
Exercise/Conversion
Allogene Therapeutics, Inc.$ALLO
Stock Option (Right to Buy)
2021-05-24−27,410→ 541,190 total
Award
Allogene Therapeutics, Inc.$ALLO
Stock Option (Right to Buy)
2021-03-26+298,836→ 298,836 total
Award
Allogene Therapeutics, Inc.$ALLO
Common Stock
2021-03-26+80,452→ 2,284,869 total
Sale
Allogene Therapeutics, Inc.$ALLO
Common Stock
2021-03-15$38.57/sh−20,513→ 2,204,417 total
Gift
Allogene Therapeutics, Inc.$ALLO
Common Stock
2020-08-31+205,778→ 856,044 total
Gift
Allogene Therapeutics, Inc.$ALLO
Common Stock
2020-08-31+205,778→ 856,044 total
Other
Allogene Therapeutics, Inc.$ALLO
Common Stock
2020-04-24+9,187→ 2,224,101 total
Other
Allogene Therapeutics, Inc.$ALLO
Common Stock
2020-04-24+9,198→ 1,201,108 total
Award
Allogene Therapeutics, Inc.$ALLO
Stock Option (Right to Buy)
2020-03-18+568,600→ 568,600 total
Gift
Allogene Therapeutics, Inc.$ALLO
Common Stock
2020-03-18+428,022→ 650,266 total
Gift
Allogene Therapeutics, Inc.$ALLO
Common Stock
2020-03-18+428,022→ 650,266 total
Sale
Allogene Therapeutics, Inc.$ALLO
Common Stock
2020-03-16$20.06/sh−1,625→ 2,214,914 total
Sale
Allogene Therapeutics, Inc.$ALLO
Common Stock
2020-03-16$19.24/sh−18,710→ 2,215,426 total
Other
Allogene Therapeutics, Inc.$ALLO
Common Stock
2020-03-04+9,402→ 1,191,910 total
Other
Allogene Therapeutics, Inc.$ALLO
Common Stock
2020-03-04+9,391→ 2,234,136 total
Other
Allogene Therapeutics, Inc.$ALLO
Common Stock
2019-11-19+9,391→ 2,224,745 total
Other
Allogene Therapeutics, Inc.$ALLO
Common Stock
2019-11-19+9,402→ 1,182,508 total
Other
Allogene Therapeutics, Inc.$ALLO
Common Stock
2019-10-25+9,402→ 1,173,106 total
Other
Allogene Therapeutics, Inc.$ALLO
Common Stock
2019-10-25+9,391→ 2,215,354 total
Other
Allogene Therapeutics, Inc.$ALLO
Common Stock
2019-09-23+9,391→ 2,205,963 total
Other
Allogene Therapeutics, Inc.$ALLO
Common Stock
2019-09-23+9,402→ 1,163,704 total
Other
Allogene Therapeutics, Inc.$ALLO
Common Stock
2019-09-05+9,402→ 1,154,302 total
Other
Allogene Therapeutics, Inc.$ALLO
Common Stock
2019-09-05+9,391→ 2,195,469 total
Other
Allogene Therapeutics, Inc.$ALLO
Common Stock
2019-07-18+9,391→ 2,186,078 total
Other
Allogene Therapeutics, Inc.$ALLO
Common Stock
2019-07-18+9,402→ 1,144,900 total
Other
Allogene Therapeutics, Inc.$ALLO
Common Stock
2019-07-10+6,388→ 2,176,687 total
Other
Allogene Therapeutics, Inc.$ALLO
Common Stock
2019-06-18+10,154→ 1,135,498 total
Other
Allogene Therapeutics, Inc.$ALLO
Common Stock
2019-05-13+11,753→ 1,125,344 total
Other
Allogene Therapeutics, Inc.$ALLO
Common Stock
2019-04-26+11,753→ 1,113,591 total
Award
Allogene Therapeutics, Inc.$ALLO
Common Stock
2019-03-13+173,000→ 2,168,625 total
Award
Allogene Therapeutics, Inc.$ALLO
Employee Stock Option (Right to Buy)
2019-03-13+292,700→ 292,700 total
Conversion
Allogene Therapeutics, Inc.$ALLO
Common Stock
2018-10-15+29,946→ 1,101,838 total
Purchase
Allogene Therapeutics, Inc.$ALLO
Common Stock
2018-10-15$18.00/sh+40,000→ 1,995,625 total
Conversion
Allogene Therapeutics, Inc.$ALLO
Series A Convertible Preferred Stock
2018-10-15−5,704→ 0 total
Disposition from Tender
Kite Pharma, Inc.
Common Stock
2017-10-03$180.00/sh−16,605→ 38,675 total
Disposition to Issuer
Kite Pharma, Inc.
Employee Stock Option (Right to Buy)
2017-10-03$173.11/sh−116,750→ 0 total

Companies

Recent Filings

Address

C/O KITE PHARMA, INC. 2225 COLORADO AVENUE

SANTA MONICA, CA, 90404

View on SEC.gov